Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.


OBJECTIVE The kinetics of recovery for innate immune effectors following antiretroviral therapy are unknown. DESIGN AND METHODS Multiple sequential cryopreserved samples (viremic and ART-suppressed) from 66 patients enrolled in the Women's Interagency HIV Study or Multicenter AIDS Cohort Study cohorts (median follow-up, 700 days) were analyzed to… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics